维普中文期刊产品整合服务
98篇 您的检索式:作者名="Litchie"
    题名 作者 年代 出处 被引量
1Variablesinfluencing neuropathic endpoints: the Rochester Diabetic Neuropathy Study of healthy subjects显示文摘Dyck P J Litchy WJ Lehman KA 1995Neurology1995,45,6:1
2Efficacy and safety of antioxidant treatment with alpha-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial 显示文摘Ziegler D Low PA Litchy WJ 2011Diabe- tes Care2011,34,9:1
3Rituximab as first-line and maintenance therapy for patients with indolent non-Hodgkin ' s lymphoma 显示文摘HAINSWORTH J D LITCHY S BURRIS H A 2002JCO2002,20,20:1
4A population-based study of Rochester,Minnesota,1976 through 1990显示文摘Radhakrishnan K Litchy WJ O'Fallon WM 1994Epidem Cervi Rad1994,117,:1
5Phase II trial of paclitaxel,carboplatin,and etoposide in advanced poorly differentiated neuroendocrine carcinoma: a minnie pearl cancer research network study 显示文摘John DH David R Litchy S 2006J Clin Oncol2006,24,22:1
6Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester Diabetic Neuropathy Study cohort 显示文摘Dyck PJ Davies JL Litchy WJ 1997Neurology1997,49,1:1
7Paclitaxel,carboplatin, and gemcitabine in the treatment of patients with advanced transitional cell carcinoma of the urothelium显示文摘Hainsworth JD Meluch AA Litchy S 2005Cancer2005,103,:1
8Sural sensory action petential identifies diabetic peripheral neuropathy responders to therapy显示文摘Vinik AI Bril V Litchy W J 2005Muscle Nerve2005,32,5:1
9Activation of peroxisome proliferator-activated receptors alpha and γ1 inhibits human smooth muscle cell proliferation显示文摘 Yurkova N Litchie B 2003Mol Cell Biochem2003,246,:1
10The prevalence by staged severity of various types of diabetic neuropathy,retinopathy,and nephropathy in a population based cohort:the rochester diabetic neuropathy study显示文摘Dyck PJ Kratz KM Karnes JL Litchy WJ Klein R Pach JM 1993Neurology1993,43,4:1
11Sural sensory action potential identifies diabetic peripheral neuropathy re- sponders to therapy显示文摘Vinik AI Bril V Litchy WJ 2005Muscle Nerve2005,32,5:1
12Maximising therapeutic benefit of Rituximab : maintenance therapy versus re - treatment at progression in patients with indolent non - Hodgkin's lymphoma - a randomized phase II trial of the Minnie Pearl Cancer Research Network 显示文摘Hainsworth J Litchy S Shaffer D 2005J Clin Oncol2005,23,6:1
13Rituximab as firstline and maintenance therapy for patients with indolent nonhodgkin's lymphoma显示文摘Hainsworth JD Litchy S Burris HA 2002J Clin Oncol2002,20,20:1
14NF-κB Activation is Essential for Angiotensin II-dependent Proliferation and Migration of Vascular Smooth Muscle Cells显示文摘Peter Zahradka Jeffrey P. Werner Shelly Buhay Brenda Litchie Gail Helwer Shawn Thomas 2002Journal of Molecular and Cellular Cardiology2002,,12:1
15Epidemiology of cervical radiculopathy: a populationbased study from Rochester, Min- nesota, 1976 through 1990显示文摘Radhakrislman K Litchy WJ O'Fallon WM 1994Brain1994,117,2:1
16Physiolog- ical prediction of muscle forces--I, theoretical formulation显示文摘KAUFMAN K R AN K W LITCHY W J 1991Neuroscience1991,40,3:1
17Activation of peroxisome proliferator-activated receptors α and γ1 inhibits human smooth muscle cell proliferation 显示文摘Zahradka P Yurkova N Litchie B 2003Molecular and Cellular Biochemistry2003,246,:1
18Maximizing therapeutic benefit of rituximab:Maintenance therapy versus re-treatment at progression in patients with indolent non-Hodgkin's lymphoma-a randomized phase Ⅱ trial of the Minnie Pearl Cancer Research Network显示文摘Hainsworth JD Litchy S Shaffer DW 2005J Clin Oncol2005,23,6:1
19Weekly docetaxel in the treatment of elderly patients with advanced nonsmall cell lung earcinoma显示文摘Hainsworth JD Burris Ⅲ HA Litchy S 2000Cancer2000,89,2:1
20Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester Diabetic Neuropathy Study cohort 显示文摘Dyck PJ Davies JL Litchy WJ 1997Neurology1997,49,:1
返回顶部 每页显示:
共5页 首页 上一页 第1页 下一页 末页 /5 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费